InvestSMART

CurveBeam AI Limited (ASX: CVB) - Announcements

Current share price for CVB : $0.018 0.002 (10%)+

ASX company news and announcements for CurveBeam AI Limited (CVB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CurveBeam AI Limited (CVB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CurveBeam AI Limited (CVB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CurveBeam AI Limited (CVB)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$9 Presentation at Euroz Hartleys 2025 Healthcare Forum 4 Feb 2025 9:43AM $0.115 $0.018 fallen by 84.35%
$9 Investor Presentation - Q2 FY25 Quarterly Update 29 Jan 2025 9:07AM $0.110 $0.018 fallen by 83.64%
$9 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jan 2025 9:04AM $0.110 $0.018 fallen by 83.64%
$9 Commercial Agreement with Stryker expanded to Aust & NZ 28 Jan 2025 9:10AM $0.115 $0.018 fallen by 84.35%
$9 Timing of Q2 Quarterly Results Investor Webinar 21 Jan 2025 3:15PM $0.125 $0.018 fallen by 85.60%
$9 Change in substantial holding - CVB in itself 19 Dec 2024 4:55PM $0.115 $0.018 fallen by 84.35%
$9 Ceasing to be a substantial holder - Greg Brown 19 Dec 2024 4:31PM $0.115 $0.018 fallen by 84.35%
$9 Change of Director's Interest Notice - Kate Robb 16 Dec 2024 5:27PM $0.130 $0.018 fallen by 86.15%
$9 Change of Director's Interest Notice - Hashan De Silva 16 Dec 2024 5:26PM $0.130 $0.018 fallen by 86.15%
$9 Change of Director's Interest Notice - Rob Lilley 16 Dec 2024 5:26PM $0.130 $0.018 fallen by 86.15%
$9 Change of Director's Interest Notice - Arun Singh 16 Dec 2024 5:24PM $0.130 $0.018 fallen by 86.15%
$9 Change of Director's Interest Notice - Greg Brown 16 Dec 2024 5:23PM $0.130 $0.018 fallen by 86.15%
$9 Notification regarding unquoted securities - CVB 16 Dec 2024 2:45PM $0.130 $0.018 fallen by 86.15%
$9 Notification regarding unquoted securities - CVB 16 Dec 2024 8:19AM $0.125 $0.018 fallen by 85.60%
$9 Application for quotation of securities - CVB 13 Dec 2024 5:29PM $0.125 $0.018 fallen by 85.60%
$9 Application for quotation of securities - CVB 13 Dec 2024 4:31PM $0.125 $0.018 fallen by 85.60%
$9 Change of Director's Interest Notice - Greg Brown 11 Dec 2024 12:21PM $0.130 $0.018 fallen by 86.15%
$9 Change of Director's Interest Notice - Rob Lilley 10 Dec 2024 8:57AM $0.125 $0.018 fallen by 85.60%
$9 Change of Director's Interest Notice - Hashan De Silva 29 Nov 2024 9:22AM $0.120 $0.018 fallen by 85%
$9 Change of Director's Interest Notice - Kate Robb 28 Nov 2024 9:25AM $0.100 $0.018 fallen by 82%
$9 Results of Meeting - AGM FY2024 26 Nov 2024 1:56PM $0.105 $0.018 fallen by 82.86%
$9 CEO Presentation for FY2024 AGM 26 Nov 2024 8:25AM $0.100 $0.018 fallen by 82%
$9 Bell Potter Healthcare Conference Presentation 20 Nov 2024 11:42AM $0.110 $0.018 fallen by 83.64%
$9 Progress on validation of HiRise for robotic surgical system 19 Nov 2024 9:39AM $0.105 $0.018 fallen by 82.86%
$9 Notification of cessation of securities - CVB 4 Nov 2024 11:54AM $0.099 $0.018 fallen by 81.82%

101 - 125 of 292 results

Page 5 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.